A detailed history of Richardson Financial Services Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Richardson Financial Services Inc. holds 1,510 shares of GILD stock, worth $175,462. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,510
Holding current value
$175,462
% of portfolio
0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 24, 2025

BUY
$96.91 - $113.0 $146,334 - $170,630
1,510 New
1,510 $169 Million
Q4 2023

Mar 04, 2024

BUY
$73.27 - $83.09 $290,515 - $329,451
3,965 New
3,965 $321 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $146B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Richardson Financial Services Inc. Portfolio

Follow Richardson Financial Services Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richardson Financial Services Inc., based on Form 13F filings with the SEC.

News

Stay updated on Richardson Financial Services Inc. with notifications on news.